NCT05335993 2026-04-03A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.CanariaBio Inc.Phase 2 Active not recruiting10 enrolled
NCT05605535 2026-04-01Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian CancerCanariaBio Inc.Phase 2 Active not recruiting88 enrolled